SCHEMBL16624855

SCHEMBL16624855

COC(=O)[C@@H]1CCCC[C@H]1C(=O)Cc1ccc(C(=O)OC(C)(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.41
CYP2C19 P33261 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.38
SIRT1 Q96EB6 1/20 0.38
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.38
KMT2A Q03164 1/20 0.38
EPHX1 P07099 1/20 0.37
ALDH1A1 P00352 2/20 0.37
EPHX2 P34913 1/20 0.37
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
CYP3A4 P08684 1/20 0.36
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16618087 0.84 KDM1A (0.37) SIRT2SIRT1MEN1KMT2AALDH1A1
SCHEMBL16618089 0.84 KDM1A (0.37) SIRT2SIRT1MEN1KMT2AALDH1A1
SCHEMBL16624856 0.83 KMT2A (0.43) SLC6A2CYP2C19POLBKMT2AEPHX1
SCHEMBL16618196 0.79 SMN1; SMN2 (0.53) SLC6A2MEN1KMT2AALDH1A1EPHX2
SCHEMBL16618194 0.79 SMN1; SMN2 (0.53) SLC6A2MEN1KMT2AALDH1A1EPHX2
SCHEMBL18440290 0.76 SLC6A2 (0.48) SLC6A2MEN1KMT2AALDH1A1EPHX2
SCHEMBL2440071 0.74 SMN1; SMN2 (0.55) MEN1KMT2AALDH1A1CA12CA1
SCHEMBL1296390 0.72 SLC6A2 (0.46) SLC6A2EPHX1SLC6A4SMN1; SMN2
SCHEMBL19432971 0.71 SIRT2 (0.39) CYP2C19SIRT2SIRT1MEN1POLB
SCHEMBL1000794 0.71 NR1H4 (0.49) ALDH1A1EPHX2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9458181-B2 Cathepsin cysteine protease inhibitors MERCK SHARP & DOHME CORP. (US) 2016-10-04 US disclosed
US-20150099719-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK SHARP & DOHME LLC 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099719-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS CTSB, CTSS, CTSZ SLC6A2 4308/4885CYP2C19 3731/4885SIRT2 1119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.